Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
OBJECTIVE
We studied the efficacy of topically applied lodoxamide tromethamine 0.1% in the treatment of superior limbic keratoconjunctivitis.


METHODS
Three patients with clinical findings of bilateral superior limbic keratoconjunctivitis. were treated with topical lodoxamide tromethamine four times daily in both eyes.


RESULTS
While the patients were taking lodoxamide tromethamine, symptoms and objective findings resolved.


CONCLUSIONS
Topically applied lodoxamide tromethamine 0.1% is useful in the treatment of superior limbic keratoconjunctivitis. There may be a role for mast cell stabilizers in the treatment of this disorder.
Grutzmacher
R D
RD
Department of Ophthalmology, University of California, Davis, USA.
Foster
R S
RS
Feiler
L S
LS
D000287:Administration, Topical; D000328:Adult; D003228:Conjunctiva / Q000187:drug effects; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D009883:Ophthalmic Solutions; D010072:Oxamic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014325:Tromethamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D009570:Nitriles; D009883:Ophthalmic Solutions; D014325:Tromethamine; C022028:lodoxamide tromethamine; D010072:Oxamic Acid